Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211106 · ClinicalTrials.gov registry record · NA
Integrated vs Sequential Treatment for PTSD and Addiction
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
NCT01211106: Completed NA study, sponsored by VA Office of Research and Development.
NCT01211106 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 183 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01211106, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
Study Summary
The investigators are examining different treatment strategies of helping patients with PTSD and addiction.
Primary Outcome
PTSD checklist (PCL), the PCL version used with the civilian PCL. The PCL is a standardized self-report rating scale for PTSD comprising 17 items that correspond to the key symptoms of PTSD. Respondents indicate how much they have been bothered by a symptom over the past month using a 5-point (1-5) scale, circling their responses. Responses range from 1 Not at All - 5 Extremely thus the total score ranges from 17 - 85. Lower scores are associated with less severity/symptoms.
Interventions
- BEHAVIORAL Prolonged Exposure
- BEHAVIORAL Motivational Enhancement Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2011-02 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT01211106 record still lists
NCT01211106 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Prolonged Exposure is the first listed.
NCT01211106 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01211106 about?
NCT01211106 is a clinical study titled "Integrated vs Sequential Treatment for PTSD and Addiction". The investigators are examining different treatment strategies of helping patients with PTSD and addiction.
What is the current status of trial NCT01211106?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2011-02. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01211106?
The interventions under investigation include: Prolonged Exposure (BEHAVIORAL), Motivational Enhancement Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01211106?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01211106's enrollment target sits among peer trials
183 584th of 2000 higher than 1,417 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia